{
  "documentMetadata": {
    "title": "IV Line Infection, Tunneled Catheters",
    "lastUpdated": "2024-06-06",
    "sourceFile": "IV Line Infection, Tunneled Catheters.pdf"
  },
  "content": [
    {
      "type": "header",
      "level": 1,
      "text": "Clinical Setting"
    },
    {
      "type": "list",
      "items": [
        "Unexplained fever in patient with IV access via a tunneled catheter.",
        "Evidence of infected IV line with one of the following types of \"tunneled\" access:",
        "Subclavian tunneled catheter (Broviac, Hickman, Groshong, Quinton)",
        "Chest-wall port",
        "Dual lumen hemodialysis access catheter: e.g. Permacath",
        "Special populations (impaired host) with infected IV line:",
        "Burn patient, neutropenic patient",
        "Chronic hyperalimentation",
        "Use of IV lipid emulsions",
        "Beware of occult infection in clotted hemodialysis grafts.",
        "May be Detected by indium scan",
        "For review of arteriovenous access for hemodialysis: JAMA 2024; 331:1307"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Diagnosis"
    },
    {
      "type": "list",
      "items": [
        "Diagnosis based on positive blood cultures and/or culture of the tip of the catheter if it is removed.",
        "Blood culture drawn through the line is positive 2 or more hours sooner than blood cultures from a peripheral vein.",
        "Semi-quantitative culture (roll-tube method) of the tip of a removed catheter grows >15 colonies of a putative pathogen."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Etiologies"
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Tunneled IV Line:"
        },
        {
          "type": "list",
          "items": [
            "Staphylococcus aureus",
            "Staphylococcus epidermidis",
            "Leuconostoc or Lactobacillus",
            "Other pathogens possible: e.g., gram-negative bacilli, Candida sp."
          ]
        }
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Burn or neutropenic patient, etiologies expand to include:"
        },
        {
          "type": "list",
          "items": [
            "Pseudomonas sp.",
            "Enterobacteriaceae",
            "Corynebacterium jeikeium"
          ]
        }
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Long-term alimentation:"
        },
        {
          "type": "list",
          "items": [
            "Candida sp."
          ]
        }
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Primary Regimens"
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Empiric therapy:"
        },
        {
          "type": "regimen",
          "regimenData": {
            "intent": "treatment",
            "condition": "Non-neutropenic and not a burn patient",
            "components": [
              {
                "drug": "Vancomycin",
                "dose": "15-20 mg/kg",
                "route": "IV",
                "frequency": "q8-12h"
              }
            ],
            "notes": "to achieve preferred target AUC24 400-600 µg/mL x hr (see vancomycin AUC dosing calculator; alternative is trough of 15-20 µg/mL)"
          }
        },
        {
          "type": "regimen",
          "regimenData": {
            "intent": "treatment",
            "condition": "Neutropenic or a burn patient",
            "components": [
              {
                "drug": "Vancomycin"
              },
              {
                "drug": "high dose Piperacillin-tazobactam",
                "connector": "+"
              }
            ],
            "notes": "for possible P. aeruginosa infection"
          }
        }
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Specific therapy (positive blood and /or catheter culture):"
        },
        {
          "type": "list",
          "items": [
            "If Staph. aureus in blood or subcutaneous tunnel is infected, generally must remove the line plus antimicrobial therapy to achieve cure"
          ]
        },
        {
          "type": "regimen",
          "regimenData": {
            "intent": "treatment",
            "condition": "Staph. aureus or Staph. epidermidis",
            "components": [
              {
                "drug": "Vancomycin",
                "dose": "15-20 mg/kg",
                "route": "IV",
                "frequency": "q8-12h"
              }
            ],
            "notes": "to achieve preferred target AUC24 400-600 µg/mL x hr (see vancomycin AUC dosing calculator; alternative is trough of 15-20 µg/mL)."
          }
        },
        {
          "type": "list",
          "items": [
            "Lactobacillus or Leuconostoc are intrinsically resistant to vancomycin; use Penicillin G, Ampicillin or Clindamycin"
          ]
        }
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Alternative Regimens"
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Empiric therapy: Burn or neutropenic patient:"
        },
        {
          "type": "regimen",
          "regimenData": {
            "intent": "treatment",
            "components": [
              {
                "drug": "Vancomycin"
              },
              {
                "drug": "Cefepime",
                "connector": "+"
              },
              {
                "drug": "Ceftazidime",
                "connector": "or"
              }
            ]
          }
        },
        {
          "type": "regimen",
          "regimenData": {
            "intent": "treatment",
            "components": [
              {
                "drug": "Vancomycin"
              },
              {
                "drug": "Piperacillin-tazobactam",
                "connector": "+"
              }
            ]
          }
        },
        {
          "type": "regimen",
          "regimenData": {
            "intent": "treatment",
            "components": [
              {
                "drug": "Vancomycin"
              },
              {
                "drug": "Imipenem",
                "connector": "+"
              },
              {
                "drug": "Meropenem",
                "connector": "or"
              },
              {
                "drug": "Doripenem",
                "connector": "or"
              }
            ]
          }
        }
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Empiric therapy: Patients requiring long-term alimentation (Candida infection a potential problem):"
        },
        {
          "type": "regimen",
          "regimenData": {
            "intent": "treatment",
            "components": [
              {
                "drug": "Anidulafungin"
              },
              {
                "drug": "Micafungin",
                "connector": "or"
              },
              {
                "drug": "Caspofungin",
                "connector": "or"
              }
            ]
          }
        },
        {
          "type": "list",
          "items": [
            "Usually must remove the line."
          ]
        }
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Comments"
    },
    {
      "type": "list",
      "items": [
        "In burn patients, suppurative phlebitis often necessitates surgical excision of the vein.",
        "Ophthalmologic consult recommended for patients with Candidemia.",
        "IV lipid emulsions (Intralipid) are prone to infection with Staph. epidermidis and occasionally Malassezia furfur (responds to azoles).",
        "IDSA Practice Guidelines: Clin Infect Dis 49:1, 2009."
      ]
    }
  ]
}